Vitamin B1 (Thiamine) Deficiency (Dry Beriberi)
Overview
Plain-Language Overview
Vitamin B1 (Thiamine) Deficiency (Dry Beriberi) is a condition caused by a lack of thiamine, a vital vitamin that helps the body convert food into energy. This deficiency mainly affects the nervous system, leading to problems with muscle strength and coordination. People with this condition often experience weakness, numbness, and difficulty walking due to nerve damage. It can also cause burning sensations in the feet and hands. Without enough thiamine, the nerves cannot function properly, which impacts daily activities and overall health.
Clinical Definition
Vitamin B1 (Thiamine) Deficiency (Dry Beriberi) is a neurological disorder resulting from insufficient thiamine, an essential cofactor for enzymes in carbohydrate metabolism such as pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase. The deficiency impairs energy production in neurons, leading to peripheral neuropathy characterized by symmetric distal muscle weakness, sensory loss, and diminished reflexes. It is commonly caused by malnutrition, chronic alcoholism, or malabsorption. The condition is distinguished from wet beriberi by the absence of significant cardiovascular involvement. Early recognition is critical to prevent irreversible nerve damage and progression to more severe neurological deficits.
Inciting Event
Prolonged inadequate dietary intake of thiamine is the primary trigger.
Excessive alcohol consumption impairs thiamine absorption and utilization.
Gastrointestinal surgery or disease causing malabsorption initiates deficiency.
High carbohydrate load without thiamine supplementation increases metabolic demand.
Latency Period
Symptoms typically develop after 2 to 3 weeks of severe thiamine deficiency.
Neurologic manifestations may appear within 1 month of inadequate intake.
Latency can be shorter in the setting of high metabolic stress or glucose infusion.
Diagnostic Delay
Symptoms are often misattributed to alcoholic neuropathy or other neuropathies.
Lack of awareness of nutritional deficiencies in developed countries delays diagnosis.
Non-specific early symptoms such as fatigue and paresthesias are overlooked.
Absence of routine thiamine level testing and reliance on clinical suspicion causes delay.
Clinical Presentation
Signs & Symptoms
Symmetric distal paresthesias and numbness in feet and hands
Muscle weakness and cramps primarily in lower limbs
Burning sensations and pain in affected extremities
Difficulty walking due to sensory ataxia and weakness
Fatigue and irritability from systemic thiamine deficiency
History of Present Illness
Patients report progressive symmetric distal limb weakness and numbness over weeks.
There is often a history of burning pain and paresthesias in the feet and hands.
Symptoms typically start in the lower extremities and ascend proximally.
Patients may describe gait instability due to sensory and motor deficits.
Chronic cases show muscle wasting and areflexia in affected limbs.
Past Medical History
Chronic alcohol use disorder is frequently documented.
History of malnutrition or poor dietary intake is common.
Previous gastrointestinal surgery or malabsorption syndromes may be present.
Prior episodes of Wernicke encephalopathy or other thiamine deficiency syndromes may be noted.
Family History
There is no significant heritable pattern associated with dry beriberi.
Family history is typically non-contributory for thiamine deficiency neuropathy.
Rare genetic disorders affecting thiamine transport or metabolism are distinct and not typical in dry beriberi.
Physical Exam Findings
Symmetric peripheral neuropathy with decreased deep tendon reflexes and distal muscle weakness
Muscle atrophy predominantly in the lower extremities
Decreased vibratory and position sense indicating sensory neuropathy
Wrist and foot drop due to motor nerve involvement
Dry, scaly skin and mild edema in affected limbs
Diagnostic Workup
Diagnostic Criteria
Diagnosis of dry beriberi is based on clinical presentation of symmetric peripheral neuropathy with distal muscle weakness and sensory deficits in the context of risk factors for thiamine deficiency. Laboratory confirmation includes low blood or erythrocyte transketolase activity, which reflects thiamine status. Neurophysiological studies such as nerve conduction velocity tests demonstrate axonal neuropathy. Response to thiamine supplementation can also support the diagnosis if symptoms improve rapidly.
Pathophysiology
Key Mechanisms
Thiamine (vitamin B1) deficiency impairs activity of thiamine-dependent enzymes such as pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, and transketolase, leading to decreased ATP production and accumulation of toxic metabolites.
Neuronal energy failure causes axonal degeneration and peripheral neuropathy characteristic of dry beriberi.
Impaired nerve conduction results from myelin sheath damage and axon loss in peripheral nerves.
Oxidative stress and mitochondrial dysfunction contribute to neuronal injury in the peripheral nervous system.
| Involvement | Details |
|---|---|
| Organs | Peripheral nervous system is the primary organ system affected, manifesting as symmetric sensorimotor polyneuropathy. |
Heart involvement is minimal in dry beriberi but must be differentiated from wet beriberi which affects cardiac function. | |
| Tissues | Peripheral nerves undergo demyelination and axonal degeneration causing the characteristic neuropathy of dry beriberi. |
Skeletal muscle tissue exhibits weakness and atrophy due to impaired energy production. | |
| Cells | Neurons are primarily affected due to impaired energy metabolism leading to axonal degeneration in dry beriberi. |
Schwann cells are involved in peripheral nerve myelination and are damaged secondary to thiamine deficiency. | |
| Chemical Mediators | Thiamine pyrophosphate (TPP) is the active coenzyme form of thiamine critical for enzymatic reactions in energy metabolism. |
Transketolase activity is decreased in erythrocytes and serves as a biochemical marker of thiamine deficiency. |
Treatments
Pharmacological Treatments
Thiamine (Vitamin B1) supplementation
- Mechanism:
Replenishes thiamine, a cofactor essential for carbohydrate metabolism and neuronal function.
- Side effects:
Allergic reactions
Injection site pain
Rare anaphylaxis
- Clinical role:
First-line
Non-pharmacological Treatments
Dietary modification to include thiamine-rich foods such as whole grains, legumes, and pork.
Avoidance of alcohol which impairs thiamine absorption and utilization.
Supportive care including physical therapy to improve muscle strength and coordination.
Prevention
Pharmacological Prevention
Oral or parenteral thiamine supplementation in at-risk populations
Multivitamin preparations containing vitamin B1 for chronic alcoholics
Intravenous thiamine administration in malnourished or hospitalized patients
Prophylactic thiamine before glucose infusion in suspected deficiency
Regular monitoring and replacement in patients with malabsorption
Non-pharmacological Prevention
Balanced diet rich in whole grains, legumes, and nuts to ensure adequate thiamine intake
Avoidance of excessive alcohol consumption to prevent malnutrition
Nutritional counseling for patients with malabsorption or bariatric surgery
Screening for thiamine deficiency in high-risk groups such as chronic alcoholics
Early rehabilitation and physical therapy to maintain muscle strength and function
Outcome & Complications
Complications
Progressive peripheral neuropathy causing permanent disability
Wernicke encephalopathy if deficiency worsens or involves CNS
Cardiomyopathy (wet beriberi) in severe systemic deficiency
Muscle wasting and contractures from chronic denervation
Increased risk of falls and injuries due to sensory and motor deficits
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Vitamin B1 (Thiamine) Deficiency (Dry Beriberi) versus Guillain-Barré Syndrome
Vitamin B1 (Thiamine) Deficiency (Dry Beriberi) | Guillain-Barré Syndrome |
|---|---|
Gradual onset of symmetric distal weakness and sensory loss over weeks to months | Rapidly progressive ascending paralysis over days to weeks |
Normal cerebrospinal fluid studies | Elevated cerebrospinal fluid protein with normal cell count (albuminocytologic dissociation) |
Improvement with thiamine supplementation | Improvement with intravenous immunoglobulin or plasmapheresis |
Vitamin B1 (Thiamine) Deficiency (Dry Beriberi) versus Chronic Alcoholic Neuropathy
Vitamin B1 (Thiamine) Deficiency (Dry Beriberi) | Chronic Alcoholic Neuropathy |
|---|---|
May or may not have alcohol use; primary thiamine deficiency | History of chronic heavy alcohol use |
Symmetric distal neuropathy with possible acute worsening in deficiency | Slowly progressive distal symmetric sensorimotor neuropathy |
Low serum thiamine levels | Normal thiamine levels; evidence of liver disease |
Vitamin B1 (Thiamine) Deficiency (Dry Beriberi) versus Vitamin B12 Deficiency
Vitamin B1 (Thiamine) Deficiency (Dry Beriberi) | Vitamin B12 Deficiency |
|---|---|
Low serum thiamine without methylmalonic acid elevation | Low serum vitamin B12 with elevated methylmalonic acid and homocysteine |
Peripheral neuropathy without posterior column involvement | Subacute combined degeneration causing posterior column and corticospinal tract signs |
Improvement with thiamine supplementation | Improvement with vitamin B12 injections |
Vitamin B1 (Thiamine) Deficiency (Dry Beriberi) versus Hypothyroid Neuropathy
Vitamin B1 (Thiamine) Deficiency (Dry Beriberi) | Hypothyroid Neuropathy |
|---|---|
Normal thyroid function tests | Elevated TSH with low free T4 |
Neuropathy without systemic hypothyroid signs | Slowly progressive neuropathy with myxedema features |
Improvement with thiamine supplementation | Improvement with thyroid hormone replacement |
Vitamin B1 (Thiamine) Deficiency (Dry Beriberi) versus Charcot-Marie-Tooth Disease
Vitamin B1 (Thiamine) Deficiency (Dry Beriberi) | Charcot-Marie-Tooth Disease |
|---|---|
No familial pattern; acquired deficiency | Autosomal dominant inheritance with family history |
Adult onset related to nutritional deficiency | Childhood or adolescence onset |
Subacute or chronic neuropathy with possible acute worsening | Chronic slowly progressive distal muscle wasting and sensory loss |